The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop ...

Cathie Wood is known for seizing opportunities. The founder of Ark Invest doesn't worry when one of the stocks she's invested ...

More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, ...

On Wednesday morning, Poland shot down several Russian drones that entered its airspace—a first since Moscow’s invasion of ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene editing tools such as CRISPR ...

6."The ozone layer is actually healing faster than expected. Scientists think it could be fully restored in our lifetime." ...

Baltimore played a role in virtually every important national debate over the use and potential misuse of the science of ...

As China threatens to overtake U.S. leadership in science and technology, America has responded by sabotaging its own engines ...